Caseware UK (AP4) 2025.0.111 2025.0.111 2025-04-0122truefalseNo description of principal activityThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 09865009 2025-04-01 2026-03-31 09865009 2024-04-01 2025-03-31 09865009 2026-03-31 09865009 2025-03-31 09865009 c:Director1 2025-04-01 2026-03-31 09865009 d:CurrentFinancialInstruments 2026-03-31 09865009 d:CurrentFinancialInstruments 2025-03-31 09865009 c:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 09865009 c:FullAccounts 2025-04-01 2026-03-31 09865009 c:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 09865009 c:Micro-entities 2025-04-01 2026-03-31 09865009 e:PoundSterling 2025-04-01 2026-03-31 iso4217:GBP xbrli:pure

Registered number: 09865009










GC Gynaecological Histopathology Consultancy Limited








Unaudited

Financial statements

Information for filing with the registrar

For the year ended 31 March 2026

 
GC Gynaecological Histopathology Consultancy Limited
Registered number: 09865009

Statement of financial position
As at 31 March 2026

2026
2025
£
£


Current assets
36,264
25,997

Creditors: amounts falling due within one year
(17,369)
(15,680)

Net current assets
 
 
18,895
 
 
10,317

Total assets less current liabilities
18,895
10,317


Net assets
18,895
10,317



Capital and reserves
18,895
10,317


Notes


General information

GC Gynaecological Histopathology Consultancy Limited is a private company, limited by shares, registered in
England and Wales. The Company's registered number is 09865009 and registered office is 1 The Green,
Richmond, Surrey, TW9 1PL.


Average number of employees

The average monthly number of employees, including directors, during the year was 2 (2025 - 2).

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 17 October 2026.




Dr G A Culora
Director


Page 1